Mr. Krouse founded Tau Therapeutics in 2005 and has been recognized for his leadership in the industry as a CIT GAP 50 Entrepreneur in the Commonwealth of Virginia and as Treasurer of the Virginia Biotechnology Association. He has three patents in the T-type calcium channel space. Prior to founding Tau, he worked for sixteen years in senior university leadership including Vice President of the University of Virginia, Darden School Foundation. He also previously served as an analyst at Goldman Sachs, NYC. Mr. Krouse is a cum laude graduate of the University of Maryland Business School. He received his MALS from Georgetown University and completed the Executive Program at the University of Virginia Darden Business School.